The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Olexenko L.V.

National Research Center for Hematology, Moscow, Russia

Vybornykh D.E.

National Research Center for Hematology, Moscow, Russia

Mental disorders in Hodgkin’s Lymphoma

Authors:

Olexenko L.V., Vybornykh D.E.

More about the authors

Read: 8631 times


To cite this article:

Olexenko LV, Vybornykh DE. Mental disorders in Hodgkin’s Lymphoma. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(8):124‑131. (In Russ.)
https://doi.org/10.17116/jnevro201711781124-131

Recommended articles:
A case of rare here­ditary Siddiqi syndrome with novel neuropsychiatric signs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):171-176
FA2H gene-associated spastic para­plegia (SPG35) — fami­lial case with late onset. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):137-144
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Mental health protection in the primary health care: medico-social effe­ctiveness. Russian Journal of Preventive Medi­cine. 2024;(10):29-35

References:

  1. Schklovsky-Kordi N, Kalmikova M, Ivaschkina M, Pivnik A. Psychological portret of HD-patient. Leuk Lymphoma. 1998;29:1:38. https://doi.org/10.3109/10428199809066342
  2. Devlen J, Maguire P, Phillips P, Crowther D, Chambers H. Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study. Br Med J. 1987;295:17:955-957. https://doi.org/10.1136/bmj.295.6604.955
  3. dos Santos MJ, Pimentel P, Monteiro JM, Cardoso G, de Oliveira JJ, Almiro M, Santos JM, de Lacerda JM. Psychiatric disorders in hospitalized patients with hematologic neoplasms. Acta Med Port. 1991;4:1:5-8.
  4. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life. J Clin Oncol. 2002;20:3137-3148. https://doi.org/10.1200/JCO.2002.08.549
  5. Oerlemans S, Mols F, Nijziel MR, Zijlstra WP, Coebergh JWW, van de Poll-Franse L V. The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. J Cancer Surviv. 2014;8(4):555-564. https://doi.org/10.1007/s11764-014-0367-1
  6. Daniels LA, Oerlemans S, Krol ADG, Creutzberg CL, van de Poll-Frans LV. Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer. 2014;110:868-874. https://doi.org/10.1038/bjc.2013.779
  7. Roswit B, Pisetsky JE. Toxic psychosis following nitrogen mustard therapy. J Nerv Ment Dis. 1952;115(4):356-359. https://doi.org/10.1097/00005053-195201000-00029
  8. Braun H, Eicke WJ. Symptomatic psychosis in nitrogen-mustard treatment of a lymphogranulomatosis. Nervenarzt. 1955;26(2):71-73.
  9. Mann AM, Hutchinson JL. Manic Reaction Associated with Procarbazine Hydrochloride Therapy of Hodgkin’s Disease. Canad Med Ass J. 1967;97(25):1350-1353.
  10. Carney MW, Ravindran A, Lewis DS. Manic psychosis associated with procarbazine. BMJ. 1982;284(6309):82-83. https://doi.org/10.1136/bmj.284.6309.82-a
  11. Rosenberg I, Mekinulov B, Cohen LJ, Galynker I. Restarting clozapine treatment during ablation chemotherapy and stem cell transplant for Hodgkin’s lymphoma. Am J Psychiatry. 2007;164(9):1438-1439. https://doi.org/10.1176/appi.ajp.2007.06122021
  12. Vybornykh DE. Vliyanie psikhotropnykh preparatov na sistemu krovetvoreniya. Sotsial’naya i klinicheskaya psikhiatriya. 2002;12(4):71-79. (In Russ.).
  13. Folks DG, Alexander AI, Rabin PL. Psychiatric Disturbance in Hodgkin’s Disease. The Southern medical journal. 1984;76:1094-1095:1100. https://doi.org/10.1097/00007611-198309000-00006
  14. Tselibeev BA, Yashish IL, Okunev VN. Psikhicheskie narusheniya pri gematologicheskikh zabolevaniyakh. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1964;64(8):1192-1197. (In Russ.).
  15. Salles P. Hodgkin’s disease: an ethno-psychiatric aspect (Apropos of a case in an African). Ann Med Psychol (Paris). 1960;118(2):728-733.
  16. Mian I, Gearing R, DeSouza C, Solomon L. Corticosteroid-related psychiatric complications in the treatment of Hodgkin’s lymphoma in an adolescent. J Can Acad Child Adolesc Psychiatry. 2007;16(1):27-29.
  17. Vybornykh DE. Psikhicheskie rasstroistva u bol’nykh s zabolevaniyami sistemy krovi (tipologiya, epidemiologiya, terapiya): Dis... dokt. med. nauk. M. 2012. (In Russ.). Ссылка активна на 03.03.17. Доступно по: http://www.psychiatry.ru/cond/0/diss/2012/191 (In Russ.).
  18. Vybornykh D.E. Psikhogematologiya. M.: Prakticheskaya meditsina; 2014. (In Russ.).
  19. Tuchel J. Neurologic-psychiatric changes in lymphogranulomatosis. Psychiatr Neurol Med Psychol (Leipz). 1957;9(11):338-348.
  20. Maksimenko VI. Psikhicheskie i nervnye izmeneniya pri limfogranulematoze. In: Materialy Vtorogo Vserossiiskogo S”ezda Nevropatologov I Psikhiatrov. 1967;443-445. (In Russ.).
  21. Carr I. The Ophelia syndrome: memory loss in Hodgkin’s disease. Lancet (London, England). 1982;1(8276):844-845. http://www.ncbi.nlm.nih.gov/pubmed/6122069. https://doi.org/10.1016/s0140-6736(82)91887-6
  22. Pfliegler G, Pósán E, Glaub D, Telek B, Rak K. Hodgkin’s disease and memory loss: another case of the Ophelia syndrome. Br J Haematol. 1990;74(2):232. http://www.ncbi.nlm.nih.gov/pubmed/2317460. https://doi.org/10.1111/j.1365-2141.1990.tb02571.x
  23. Bernard P, Vinzio S, Talarmin F, Kadouri A, Flocard F. Encéphalite limbique révélatrice d’une maladie de Hodgkin. Rev Med Interne. 2003;24(4):257-260. https://doi.org/10.1016/S0248-8663(03)00053-5
  24. Fassin D. De l’invention du traumatisme à la reconnaissance des victimes. Vingtième Siècle Rev d’histoire. 2014;123(3):161. https://doi.org/10.3917/vin.123.0161
  25. de Bot ST, Dorresteijn LDA, Haaxma CA, Kappelle AC, van de Warrenburg BPC. From psychiatric symptoms to paraneoplastic syndrome. Tijdschr Psychiatr. 2008;50(9):603-609. http://www.ncbi.nlm.nih.gov/pubmed/18785107.
  26. Mat A, Adler H, Merwick A, Chadwick G, Giuseppe GF, Dalmau JO, Tubridy N. Ophelia syndrome with metabotrophic glutamat receptor 5 antibodies in CSF. Neurology. 2013;2:1349-1350. https://doi.org/10.1212/wnl.0b013e31828ab325
  27. Olmos D, Rueda A, Jurado JM, Alba E. Presentation of Hodgkin’s lymphoma with ophelia syndrome. J Clin Oncol. 2007;25(13):1802-1803. https://doi.org/10.1200/JCO.2006.10.0578
  28. Kung S, Mueller PS, Geda YE, Krahn LE. Delirium resulting from paraneoplastic limbic encephalitis caused by Hodgkin’s disease. Psychosomatics. 2002;43(6):498-501. https://doi.org/10.1176/appi.psy.43.6.498
  29. Sohn D, Valensi Q, Miller SP. Neurologic manifestations of Hodgkin’s disease. Intracerebral Hodgkin’s granuloma. Arch Neurol. 1967;17(4):429-436. http://www.ncbi.nlm.nih.gov/pubmed/4292676 https://doi.org/10.1001/archneur.1967.00470280095011
  30. Slattery C, Agius M, Zaman R. Bipolar disorder associated with paraneoplastic cerebellar degeneration: a case report. Psychiatr Danub. 2010;22(suppl 1):137-138. http://www.ncbi.nlm.nih.gov/pubmed/21057423. https://doi.org/10.1016/j.eurpsy.2008.01.398
  31. Loge JH, Abrahamsen AF, Ekeberg O, Hannisdal E, Kaasa S. Psychological distress after cancer cure: a survey of 459 Hodgkin’s disease survivors. Br J Cancer. 1997;76(6):791-796. https://doi.org/10.1038/bjc.1997.464
  32. Loge JH, Foss Abrahamsen A, Ekeberg Ø, Kaasa S. Fatigue and Psychiatric Morbidity Among Hodgkin’s Disease Survivors. J Pain Symptom Manage. 2000;19(2):91-99. https://doi.org/10.1016/s0885-3924(99)00148-7
  33. Lavoie JC, Connors JM, Phillips GL, Reece DE, Barnett MJ, Forrest DL, Gascoyne RD, Hogge DE, Nantel SH, Shepherd JD, Smith CA, Song KW, Sutherland HJ, Toze CL, Voss NJS, Nevill TJ. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: Long-term outcome in the first 100 patients treated in Vancouver. Blood. 2005;106:1473-1478. https://doi.org/10.1182/blood-2004-12-4689
  34. Kawiecka-Dziembowska B, Borkowska A, Zurawski B, Pałaszyńska R, Makarewicz R. Ocena temperamentu, jakości życia i nasilenia cech depresji u pacjentów z chorobą Hodgkina w jej rónych fazach. Psychiatr Pol. 2005;39(4):679-690. http://www.psychiatriapolska.pl/uploads/PPt39n4s679Kawiecka.pdf
  35. Weddington WW. Psychogenic Nausea and Vomiting Associated with Termination of Cancer Chemotherapy. Psychotherapy and psychosomatics. 1982;37:129-136. https://doi.org/10.1159/000287565
  36. Reesal RT, Bajramovic H, Mai F. Anticipatory nausea and vomiting: a form of chemotherapy phobia? Can J Psychiatry. 1990;35(1):80-82. http://www.ncbi.nlm.nih.gov/pubmed/1969324
  37. Cella DF, Pratt A, Holland JC. Persistent anticipatory nausea, vomiting, and anxiety in cured Hodgkin’s disease patients after completion of chemotherapy. Am J Psychiatry. 1986;143(5):641-643. https://doi.org/10.1176/ajp.143.5.641
  38. Nerenz DR, Leventhal H, Easterling D V, Love RR. Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy. J Clin Oncol. 1986;4(2):224-233. https://doi.org/10.1200/jco.1986.4.2.224
  39. Nesse RM, Carli T, Curtis GC, Kleinman PD. Pseudohallucinations in cancer chemotherapy patients. Am J Psychiatry. 1983;140:483-485. https://doi.org/10.1176/ajp.140.4.483
  40. Davidson PW. Hysterical dysphemia. Am J Psychiatry. 1964;121:395-397. https://doi.org/10.1176/ajp.121.4.395
  41. Diagnostic and Statistical Manual of Mental Disorders (4th Ed. Text Revision). Washington DC: American Psychiatric Association; 2000. https://doi.org/10.1176/appi.books.9780890423349
  42. Geffen DB, Blaustein A, Amir MC, Cohen Y. Post-traumatic stress disorder and quality of life in long-term survivors of Hodgkin’s disease and non-Hodgkin’s lymphoma in Israel. Leuk Lymphoma. 2003;44(11):1925-1929. https://doi.org/10.1080/1042819031000123573
  43. Varela VS, Ng A, Mauch P, Recklitis CJ. Posttraumatic stress disorder (PTSD) in survivors of Hodgkin’s lymphoma: Prevalence of PTSD and partial PTSD compared with sibling controls. Psycho-Oncology. 2013;22(2):434-440. https://doi.org/10.1002/pon.2109
  44. Akaho R, Sasaki T, Yoshino M, Hagiya K, Akiyama H, Sakamaki H. Bone marrow transplantation in subjects with mental disorders. Psychiatry Clin Neurosci. 2003;57(3):311-315. https://doi.org/10.1046/j.1440-1819.2003.01122.x
  45. Strauss DH, Spitzer RL, Muskin PR. Maladaptive denial of physical illness: A proposal for DSM-IV. Am J Psychiatry. 1990;147:1168-1172. https://doi.org/10.1176/ajp.147.9.1168
  46. Riskó A, Fleischmann T, Molnár Z, Schneider T, Várady E. Influence of the pathological psychological state of cancer patients on their decisions. Support Care Cancer. 1996;4(1):51-55. http://www.ncbi.nlm.nih.gov/pubmed/8771295 https://doi.org/10.1007/BF01769876
  47. Olweny CL, Juttner CA, Rofe P, et al. Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours. Eur J Cancer. 1993;29A(6):826-830. http://www.ncbi.nlm.nih.gov/pubmed/8484971
  48. Tsang RW, Solow HL, Ananthanarayan C, Haley S. Daily general anaesthesia for radiotherapy in unco-operative patients: ingredients for successful management. Clin Oncol (R Coll Radiol). 2001;13(6):416-421. http://www.ncbi.nlm.nih.gov/pubmed/11824877 https://doi.org/10.1007/s001740170004
  49. Vybornykh DE, Moiseeva TN, Gabeeva NV, Savchenko VG. Narusheniya terapevticheskogo sotrudnichestva (non-compliance) u patsientov s limfogranulematozom. Psikhicheskie rasstroistva v obshchei meditsine (pod red A.B.Smulevicha). 2009;(1):32-34. (In Russ.).
  50. Lerner DM, Schuetz L, Holland S, Rubinow DR, Rosenstein DL. Low-dose risperidone for the irritable medically ill patient. Psychosomatics. 2000;41(1):69-71. https://doi.org/10.1016/S0033-3182(00)71177-7
  51. Vybornykh DE, Savchenko VG, Moiseeva TN, Gabeeva NG. Noncompliance in the patients with Hodgkin’s disease. Psycho-Oncology. 2006;15(2 suppl):449. https://doi.org/10.1002/pon.1092
  52. Stransky E. Die paranoiden Erkrankungen. Z ges Neurol Psychiat. 1913;(18):386-416. https://doi.org/10.1007/bf02869654
  53. Stransky E. Schizophrenie und intrapsychische Ataxie. Jb Psychiat. 1914;(36):485.
  54. Pilowsky I. Abnormal illness behavior (dysnosognosia). Psychother Psychosom. 1986;46(1-2):76-84. https://doi.org/10.1159/000287964
  55. Smulevich AB. Maloprogredientnaya shizofreniya i pogranichnye sostoyaniya. 1987. (In Russ.).
  56. Kempinskii A. Psikhologiya shizofrenii. M.: Yuventa; 1998. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.